Cargando…
A Malawian pharmaceutical response to the COVID-19 Pandemic
The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi,...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Medical Association Of Malawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230587/ https://www.ncbi.nlm.nih.gov/pubmed/37265827 http://dx.doi.org/10.4314/mmj.v34i1.11 |
_version_ | 1785051565359366144 |
---|---|
author | Kachingwe, Baxter Kumpalume, Peter Khuluza, Felix Nyirenda, Kumbukani Matambo, Ernest Mponda, John Dzabala, Nettie Chiumia, Francis Chikowe, Ibrahim Chimimba, Frider Nyoloka, Nelson Alfazema, Louisa Nyirongo, Happy Smith, Dallas |
author_facet | Kachingwe, Baxter Kumpalume, Peter Khuluza, Felix Nyirenda, Kumbukani Matambo, Ernest Mponda, John Dzabala, Nettie Chiumia, Francis Chikowe, Ibrahim Chimimba, Frider Nyoloka, Nelson Alfazema, Louisa Nyirongo, Happy Smith, Dallas |
author_sort | Kachingwe, Baxter |
collection | PubMed |
description | The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time. |
format | Online Article Text |
id | pubmed-10230587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Medical Association Of Malawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-102305872023-06-01 A Malawian pharmaceutical response to the COVID-19 Pandemic Kachingwe, Baxter Kumpalume, Peter Khuluza, Felix Nyirenda, Kumbukani Matambo, Ernest Mponda, John Dzabala, Nettie Chiumia, Francis Chikowe, Ibrahim Chimimba, Frider Nyoloka, Nelson Alfazema, Louisa Nyirongo, Happy Smith, Dallas Malawi Med J Case Report The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time. The Medical Association Of Malawi 2022-03 /pmc/articles/PMC10230587/ /pubmed/37265827 http://dx.doi.org/10.4314/mmj.v34i1.11 Text en © 2022 The College of Medicine and the Medical Association of Malawi. https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Case Report Kachingwe, Baxter Kumpalume, Peter Khuluza, Felix Nyirenda, Kumbukani Matambo, Ernest Mponda, John Dzabala, Nettie Chiumia, Francis Chikowe, Ibrahim Chimimba, Frider Nyoloka, Nelson Alfazema, Louisa Nyirongo, Happy Smith, Dallas A Malawian pharmaceutical response to the COVID-19 Pandemic |
title | A Malawian pharmaceutical response to the COVID-19 Pandemic |
title_full | A Malawian pharmaceutical response to the COVID-19 Pandemic |
title_fullStr | A Malawian pharmaceutical response to the COVID-19 Pandemic |
title_full_unstemmed | A Malawian pharmaceutical response to the COVID-19 Pandemic |
title_short | A Malawian pharmaceutical response to the COVID-19 Pandemic |
title_sort | malawian pharmaceutical response to the covid-19 pandemic |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230587/ https://www.ncbi.nlm.nih.gov/pubmed/37265827 http://dx.doi.org/10.4314/mmj.v34i1.11 |
work_keys_str_mv | AT kachingwebaxter amalawianpharmaceuticalresponsetothecovid19pandemic AT kumpalumepeter amalawianpharmaceuticalresponsetothecovid19pandemic AT khuluzafelix amalawianpharmaceuticalresponsetothecovid19pandemic AT nyirendakumbukani amalawianpharmaceuticalresponsetothecovid19pandemic AT matamboernest amalawianpharmaceuticalresponsetothecovid19pandemic AT mpondajohn amalawianpharmaceuticalresponsetothecovid19pandemic AT dzabalanettie amalawianpharmaceuticalresponsetothecovid19pandemic AT chiumiafrancis amalawianpharmaceuticalresponsetothecovid19pandemic AT chikoweibrahim amalawianpharmaceuticalresponsetothecovid19pandemic AT chimimbafrider amalawianpharmaceuticalresponsetothecovid19pandemic AT nyolokanelson amalawianpharmaceuticalresponsetothecovid19pandemic AT alfazemalouisa amalawianpharmaceuticalresponsetothecovid19pandemic AT nyirongohappy amalawianpharmaceuticalresponsetothecovid19pandemic AT smithdallas amalawianpharmaceuticalresponsetothecovid19pandemic AT kachingwebaxter malawianpharmaceuticalresponsetothecovid19pandemic AT kumpalumepeter malawianpharmaceuticalresponsetothecovid19pandemic AT khuluzafelix malawianpharmaceuticalresponsetothecovid19pandemic AT nyirendakumbukani malawianpharmaceuticalresponsetothecovid19pandemic AT matamboernest malawianpharmaceuticalresponsetothecovid19pandemic AT mpondajohn malawianpharmaceuticalresponsetothecovid19pandemic AT dzabalanettie malawianpharmaceuticalresponsetothecovid19pandemic AT chiumiafrancis malawianpharmaceuticalresponsetothecovid19pandemic AT chikoweibrahim malawianpharmaceuticalresponsetothecovid19pandemic AT chimimbafrider malawianpharmaceuticalresponsetothecovid19pandemic AT nyolokanelson malawianpharmaceuticalresponsetothecovid19pandemic AT alfazemalouisa malawianpharmaceuticalresponsetothecovid19pandemic AT nyirongohappy malawianpharmaceuticalresponsetothecovid19pandemic AT smithdallas malawianpharmaceuticalresponsetothecovid19pandemic |